Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years. In the time it has taken you to ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

TSLP has been found to play a key role in different immune diseases, such as boosting inflammation in asthma and COPD. WIN378 ...